<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Although experimental studies have widely shown that the pharmacological blockade of ionotropic <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> receptors reduces ischemic damage, clinical trials with classical AMPA and <z:chebi fb="0" ids="31882">NMDA</z:chebi> <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> receptor <z:chebi fb="68" ids="48706">antagonists</z:chebi> have provided negative results </plain></SENT>
<SENT sid="1" pm="."><plain>To address the involvement of ionotropic <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> receptors in ischemic damage, corticostriatal brain slices were prepared from adult rats </plain></SENT>
<SENT sid="2" pm="."><plain>Extracellular recordings were performed in the striatum after stimulation of the glutamatergic corticostriatal fibres </plain></SENT>
<SENT sid="3" pm="."><plain>In vitro <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> was induced for a 10-min period by omitting oxygen and <z:chebi fb="105" ids="17234">glucose</z:chebi> from the external medium </plain></SENT>
<SENT sid="4" pm="."><plain>Under control conditions, <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> produced an irreversible loss of the corticostriatal field potential amplitude, AP5, a competitive <z:chebi fb="0" ids="31882">NMDA</z:chebi> receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi>, induced a slight rescue of the potential, while ifenprodil, a positive modulator of the proton sensor of the <z:chebi fb="0" ids="31882">NMDA</z:chebi> receptors, allowed a complete recovery from the ischemic insult </plain></SENT>
<SENT sid="5" pm="."><plain>Similar neuroprotection was achieved by utilizing either CNQX, a broad spectrum AMPA receptors <z:chebi fb="68" ids="48706">antagonist</z:chebi>, or Joro spider toxin, a selective blocker of calcium permeable AMPA receptors </plain></SENT>
<SENT sid="6" pm="."><plain>Interestingly, while CNZX also fully suppressed physiological excitatory transmission, Joro spider toxin was ineffective on this parameter </plain></SENT>
<SENT sid="7" pm="."><plain>Finally, lamotrigine and remacemide, two <z:chebi fb="0" ids="35623">antiepileptic</z:chebi> drugs that differentially affect excitatory transmission, exerted neuroprotective effects against <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>Noticeably, a combination of low concentrations of these two drugs exerted a stronger neuroprotection than a single drug given in isolation </plain></SENT>
<SENT sid="9" pm="."><plain>Thus, it might be possible to reach a neuroprotective action by utilizing doses of these compounds low enough to avoid side effects </plain></SENT>
<SENT sid="10" pm="."><plain>Our experimental data still support the idea that a negative modulation of excitatory transmission can be neuroprotective against <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="11" pm="."><plain>In addition, our findings support the concept that it is possible to produce a significant neuroprotective action in the absence of a relevant interference with <z:mpath ids='MPATH_458'>normal</z:mpath> synaptic transmission </plain></SENT>
</text></document>